Author/Editor     Vašku, V; Vašku, JA; Pavkova-Goldbergova, M; Vašku, A
Title     Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma
Type     članek
Source     Acta Dermatovenerol Alp Pannon Adriat
Vol. and No.     Letnik 13, št. 4
Publication year     2004
Volume     str. 111-8
ISSN     1318-4458
Language     eng
Abstract     Background. The cutaneous T cell lymphoma (CTCL) is a disease characterised by cutaneous infiltrates of malignant, clonally expanded T cells. Because individual genetic determination of angiogenetic and antioxidant properties of blood vessels could be partly responsible for phototherapy in CTCL patients, three polymorphisms in angiotensin converting enzyme and endothelin-1 genes were determined. Methods. 77 patients with CTCL, diagnosed and treated at the First Dermatological Clinic of St. Ann's Faculty Hospital Brno (46 men and 31 women, median age 62, range 26-80 years) were compared to a control non-CTCL group of the similar age and gender distribution (n=203: 137 men and 66 women, median age 54, range 27-86 years) with negative family history of severe skin diseases and without signs of malignancy. Diagnosis of CTCL was verified according to the clinical picture and histologically. The genotype distributions and allelic frequencies between CTCL with phototherapy and those without phototherapy were compared. Results. Significant differences were found in genotype distributions of insertion/deletion (I/D) ACE polymorphism between CTCL patients treated with phototherapy and those treated without it. Heterozygote ID was more frequent in the group treated with phototherapy (25/13 vs. 12/27, OR=4.33, 95% confidential interval 1.67-11.24, P=0.02). The 4A4A variant of -3A/-4A EDN1 is more frequent in patients treated with phototherapy (8/30 vs.1/38, OR=10.13,95% confidential interval 1.20-85.55, P=0.01). The GA and AA genotypes of G8002A EDN1 polymorphism are more frequent in CTCL patients treated with phototherapy compared to those without it (15/23 vs. 7/32, OR=2.98, 95% confidential interval 1.05-8.48, P=0.03). Discussion. Some polymorphic variants in ACE and EDN1 genes (a heterozygote I/D ACE, a homozyqote -4A-4A in -3A /-4A EDN1 and qenotypes GA and GG in G8002A EDN1) seem to carry an advantage for phototherapy effectiveness in patients with CTCL.
Descriptors     LYMPHOMA, T-CELL, CUTANEOUS
SKIN NEOPLASMS
PEPTIDYL-DIPEPTIDASE A
ENDOTHELIN-1
POLYMORPHISM (GENETICS)
PHOTOTHERAPY
GENOTYPE
ALLELES
POLYMERASE CHAIN REACTION